Novel Melanoma Antigen Peptide and Uses Thereof
The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.
Patents:EP 2,321,340
Inventor(s):
LABARRIERE NATHALIE [FR]; MOREAU-AUBRY AGNES [FR]; GODET YANN [FR]
Type of Offer:
Sale
« More Biotech Patents